Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
Chhanda Bose, Sanjay Awasthi, Rajendra Sharma, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0193918-e0193918
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Quan Gao, Jiao Feng, Wen‐Cheng Liu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114445-114445
Closed Access | Times Cited: 163
Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease
Christine A. Houghton
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-27
Open Access | Times Cited: 148
The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases
Xueyan Zhang, Yihan Yu, Hanyu Lei, et al.
Cardiology Research and Practice (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 140
Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
Kai Hou, Jianliang Shen, Junrong Yan, et al.
EBioMedicine (2021) Vol. 69, pp. 103456-103456
Open Access | Times Cited: 111
Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone
Muhammad Zakariyyah Aumeeruddy, Mohamad Fawzi Mahomoodally
Cancer (2019) Vol. 125, Iss. 10, pp. 1600-1611
Open Access | Times Cited: 138
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon, Kishore Banik, Choudhary Harsha, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 306-339
Closed Access | Times Cited: 123
Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission
Xinyue Liang, Shuyi Wang, Lifeng Wang, et al.
Pharmacological Research (2020) Vol. 157, pp. 104846-104846
Closed Access | Times Cited: 121
Natural compounds against doxorubicin‐induced cardiotoxicity: A review on the involvement of Nrf2/ARE signaling pathway
Fatemeh Yarmohammadi, Ramin Rezaee, Gholamreza Karimi
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1163-1175
Closed Access | Times Cited: 98
The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases
Morana Jaganjac, Lidija Milković, Agnieszka Gęgotek, et al.
Free Radical Biology and Medicine (2019) Vol. 157, pp. 128-153
Open Access | Times Cited: 90
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials
Bharti Mangla, Shamama Javed, Muhammad H. Sultan, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5440-5458
Closed Access | Times Cited: 86
Sulforaphane prevents age‐associated cardiac and muscular dysfunction through Nrf2 signaling
Chhanda Bose, Inês Alves, Preeti Singh, et al.
Aging Cell (2020) Vol. 19, Iss. 11
Open Access | Times Cited: 85
The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application
James Melrose
Biomedicines (2019) Vol. 7, Iss. 3, pp. 62-62
Open Access | Times Cited: 77
Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition
Manvi Sharma, Trygve O. Tollefsbol
Experimental Cell Research (2022) Vol. 416, Iss. 1, pp. 113160-113160
Open Access | Times Cited: 49
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 33
Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model
Anna Pogorzelska, Maciej Mazur, Marta Świtalska, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114490-114490
Open Access | Times Cited: 25
Sulforaphane: An emergent anti-cancer stem cell agent
Leandro L. Coutinho, Tharcísio Citrangulo Tortelli, María Cristina Rangel
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 23
Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
Bethsebie Lalduhsaki Sailo, Le Liu, Suravi Chauhan, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access | Times Cited: 13
The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
Jed W. Fahey, Mirran Raphaely
Applied Sciences (2025) Vol. 15, Iss. 2, pp. 522-522
Open Access | Times Cited: 1
Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy
Mario Negrette-Guzmán
European Journal of Pharmacology (2019) Vol. 859, pp. 172513-172513
Closed Access | Times Cited: 64
Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer – contradictory effects and future perspectives
Parham Jabbarzadeh Kaboli, Masoomeh Afzalipour Khoshkbejari, Mahsa Mohammadi, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109635-109635
Open Access | Times Cited: 55
Role of plant derived bioactive compounds against cancer
Arpita Roy, Shreeja Datta, Karanpreet Singh Bhatia, et al.
South African Journal of Botany (2021) Vol. 149, pp. 1017-1028
Open Access | Times Cited: 42
Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action
Raymond A. Otoo, Antiño R. Allen
Molecules (2023) Vol. 28, Iss. 19, pp. 6902-6902
Open Access | Times Cited: 20
Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
Cinzia Calcabrini, Francesca Maffei, Eleonora Turrini, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 44
Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
Cun Liu, Xiaoran Ma, Jing Zhuang, et al.
Pharmacological Research (2020) Vol. 160, pp. 105062-105062
Closed Access | Times Cited: 42
Lipid-Nanopotentiated Combinatorial Delivery of Tamoxifen and Sulforaphane: Ex Vivo , In Vivo and Toxicity Studies
Bharti Mangla, Yub Raj Neupane, Archu Singh, et al.
Nanomedicine (2020) Vol. 15, Iss. 26, pp. 2563-2583
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top